{"entity":{"type":"insider","cik":"0001636178","url":"/insider/0001636178","json_url":"/insider/0001636178.json","name":"EDGEMOND JAMES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":443,"n_filings":49,"first":"2024-05-16","last":"2026-06-23","span_basis":"filed_date"},"name_variants":[{"name":"EDGEMOND JAMES","source":"filing","n_filings":49,"first_seen":"2024-05-16","last_seen":"2026-06-23"}],"transactions":[{"id":6139457,"accession":"0001636178-26-000029","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001636178-26-000029","line_url":"/filing/0001636178-26-000029","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":538.1469308,"price_display":"538.15","price_state":"stated","total_value":4708785.6445,"total_display":"4,708,785.64","total_whole":"4,708,786","shares_owned_after":22400.0,"shares_owned_after_display":"22,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-23","scope":"insider","n_lines":8},{"id":5778575,"accession":"0001636178-26-000028","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001636178-26-000028","line_url":"/filing/0001636178-26-000028","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":540.14884992,"price_display":"540.15","price_state":"stated","total_value":5401488.4992,"total_display":"5,401,488.50","total_whole":"5,401,488","shares_owned_after":21053.0,"shares_owned_after_display":"21,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-18","filed_date":"2026-06-22","scope":"insider","n_lines":14},{"id":6077819,"accession":"0001636178-26-000027","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001636178-26-000027","line_url":"/filing/0001636178-26-000027","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":549.17420754,"price_display":"549.17","price_state":"stated","total_value":5491742.0754,"total_display":"5,491,742.08","total_whole":"5,491,742","shares_owned_after":21396.0,"shares_owned_after_display":"21,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider","n_lines":14},{"id":5987021,"accession":"0001636178-26-000026","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001636178-26-000026","line_url":"/filing/0001636178-26-000026","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":549.28938848,"price_display":"549.29","price_state":"stated","total_value":5492893.8848,"total_display":"5,492,893.88","total_whole":"5,492,894","shares_owned_after":20756.0,"shares_owned_after_display":"20,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-12","scope":"insider","n_lines":9},{"id":5922323,"accession":"0001636178-26-000025","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001636178-26-000025","line_url":"/filing/0001636178-26-000025#line-9","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2158.0,"shares_display":"2,158","price_per_share":547.9111,"price_display":"547.91","price_state":"stated","total_value":1182392.1538,"total_display":"1,182,392.15","total_whole":"1,182,392","shares_owned_after":21276.0,"shares_owned_after_display":"21,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5922320,"accession":"0001636178-26-000025","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001636178-26-000025","line_url":"/filing/0001636178-26-000025#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1989.0,"shares_display":"1,989","price_per_share":546.1339,"price_display":"546.13","price_state":"stated","total_value":1086260.3271,"total_display":"1,086,260.33","total_whole":"1,086,260","shares_owned_after":25322.0,"shares_owned_after_display":"25,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5922318,"accession":"0001636178-26-000025","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001636178-26-000025","line_url":"/filing/0001636178-26-000025#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1888.0,"shares_display":"1,888","price_per_share":547.0292,"price_display":"547.03","price_state":"stated","total_value":1032791.1296,"total_display":"1,032,791.13","total_whole":"1,032,791","shares_owned_after":23434.0,"shares_owned_after_display":"23,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5922315,"accession":"0001636178-26-000025","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001636178-26-000025","line_url":"/filing/0001636178-26-000025#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1565.0,"shares_display":"1,565","price_per_share":544.9334,"price_display":"544.93","price_state":"stated","total_value":852820.771,"total_display":"852,820.77","total_whole":"852,821","shares_owned_after":27311.0,"shares_owned_after_display":"27,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5922313,"accession":"0001636178-26-000025","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001636178-26-000025","line_url":"/filing/0001636178-26-000025#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001636178","owner_name":"EDGEMOND JAMES","owner_display_name":"EDGEMOND JAMES","owner_url":"/insider/0001636178","role":"Officer (CFO AND TREASURER)","role_mark":"O","role_mark_label":"Officer (CFO AND TREASURER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO AND TREASURER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1285.0,"shares_display":"1,285","price_per_share":550.0937,"price_display":"550.09","price_state":"stated","total_value":706870.4045,"total_display":"706,870.40","total_whole":"706,870","shares_owned_after":19566.0,"shares_owned_after_display":"19,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"}],"collapsed":true,"next_cursor":"2026-06-08|5922313","ledger_fault":false,"count":{"value":443,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":443,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":443},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001082554","name":"UNITED THERAPEUTICS Corp","url":"/issuer/0001082554","role":"Officer (CFO AND TREASURER)","n_filings":49,"first_seen":"2024-05-16","last_seen":"2026-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001636178","retrieved_at":"2026-08-24T22:09:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}